International pharmaceutical R&D company developing improved and novel drug formulations for unmet clinical needs, using proprietary controlled- and sustained-release platform technologies
International pharmaceutical R&D company developing improved and novel drug formulations for unmet clinical needs, using proprietary controlled- and sustained-release platform technologies. Its pipeline includes products for the neuropsychiatric field, including insomnia, and it develops products for China, the United States, and global markets.